Erectile dysfunction, sildenafil and cardiovascular risk

Medical Journal of Australia

Volumn 172, Issue 6, 2000, Pages 279-283

  Chew, K Kim ^a   Stuckey, Bronwyn G A ^a,c   Thompson, Peter L ^b  

^a Keogh Institute for Medical Research   (Australia)

^b UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^c PATHWEST LABORATORY MEDICINE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHYPERTENSIVE AGENT; CIMETIDINE; ERYTHROMYCIN; FLUCONAZOLE; FLUOXETINE; NITRATE; PAPAVERINE; PHENTOLAMINE; PROSTAGLANDIN E1; SILDENAFIL;

ALGORITHM; CARDIOVASCULAR RISK; DRUG BLOOD LEVEL; DRUG CONTRAINDICATION; DRUG EFFECT; DRUG HALF LIFE; DRUG MECHANISM; DRUG METABOLISM; ERECTILE DYSFUNCTION; FITNESS; HEART INFARCTION; HUMAN; ISCHEMIC HEART DISEASE; MALE; PENIS PROSTHESIS; PRACTICE GUIDELINE; REVIEW; SEXUAL BEHAVIOR;

EID: 0034689436     PISSN: 0025729X     EISSN: None     Source Type: Journal    
DOI: 10.5694/j.1326-5377.2000.tb123945.x     Document Type: Review

References (39)

1. Kiely M. Viagra saturates media. Marketing Globe. Marketing 1998; Dec: 58.
2. Jones A. When the thrill has gone. Business Rev Weekly 1999; June 25: 90-95.
3. US Department of Health, Food and Drug Administration. Postmarketing safety of sildenafil citrate (Viagra) and summary of reports of death in Viagra users received from marketing (late March through mid-November 1988). 24 November 1988.
4. Feldman HA, McKinlay JB, Goldstein I, Longcope C. Erectile dysfunction, cardiovascular disease and cardiovascular risk factors: prospective results in a large random sample of Massachusetts men. J Urol 1998; 159 Suppl 5: 91 abstract 347.
5. Chew KK, Earle CM, Stuckey BGA, et al. Erectile dysfunction in general medical practice: prevalence and clinical correlates. Int J Impot Res 2000; 12: 1-5.
6. Wabrek AJ, Burchell RC, Male sexual dysfunction associated with coronary heart disease. Arch Sex Behav 1980; 9: 69-75.
7. Gundle MJ, Reeves BR, Tate S, et al. Psychosocial outcome after aortocoronary artery surgery. Am J Psychiatry 1980; 137: 1591-1594.
8. Anderson M, Nicholson B, Louie E, Mulhall JP. An analysis of vasculogenic erectile dysfunction as a potential predictor of occult cardiac disease. J Urol 1998; 159 Suppl 5: 30 abstract 118.
9. Greenstein A, Chen J, Miller H, et al. Does severity of ischaemic coronary disease correlate with erectile function? Int J Impot Res 1997; 9: 123-126.
10. Slag MF, Morley JE, Elson MK, et al. Impotence in medical clinic outpatients. JAMA 1983; 249: 1736-1740.
11. Morales A, Gingell G, Collins M, et al. Clinical safety of sildenafil citrate (Viagra) in the treatment of erectile dysfunction. Int J Impot Res 1998; 10: 69-74.
12. Viagra - approved product information. Pfizer, 1998.
13. Boolell M, Allen MJ, Ballard SA, et al. Sildenafil: an orally active type 5 cyclic GMP-specific phosphodiesterase inhibitor for the treatment of penile erectile dysfunction. Int J Impot Res 1996; 8: 47-52.
14. Zusman RM, editor. Cardiovascular data on sildenafil citrate. Am J Cardiol 1999; 83(5A).
15. Feenstra J, van Drie-Pierik RJHM, Lacle CF, Stricker BHC. Acute myocardial infarction associated with sildenafil. Lancet 1998; 352: 957-958.
16. Viagra is here! Australian Adverse Drug Reactions Bulletin 1998; 17(4).
17. Hellerstein HK, Friedman EH. Sexual activity and the postcoronary patient. Arch Intern Med 1970; 125: 987-999.
18. Bohlen Y, Held JP, Sanderson MO, Paterson RP. Heart rate, rate-pressure product, and oxygen uptake during four sexual activities. Arch Intern Med 1974; 144: 1745-1748.
19. Willich SN, Klatt S, Arntz HR. Circadian variation and triggers of acute coronary syndromes. Eur Heart J 1998; 19 Suppl C: C12-23
20. Nalbangtil I, Yigitbasi O, Kiliccioglu B. Sudden death in sexual activity. Am Heart J 1976; 91: 405-406.
21. Ueno M. The so-called coital death. Jpn J Legal Med 1963; 17: 330-340.
22. Renshaw DC, Karstaedt A. Is there (sex) life after coronary bypass? Comp Ther 1988; 14: 61-66.
23. Lecomte D, Fornes P, Nicolas G. Stressful events as a trigger of sudden death: a study of 43 medico-legal autopsy cases. Forensic Sci Int 1996; 79: 1-10
24. Muller JE, Mittleman MA, Maclure M, et al. Triggering myocardial infarction by sexual activity. JAMA 1996; 275: 1405-1409.
25. Johnston BL, Fletcher GF. Dynamic electrocardiographic recording during sexual activity in recent post-myocardial infarction and revascularization patients. Am Heart J 1979; 98: 736-741.
26. Drory Y, Shapira I, Fisman EZ, Pines A. Myocardial ischaemia during sexual activity in patients with coronary artery disease. Am J Cardiol 1995; 75: 835-837.
27. Kavanagh T, Shephard RJ. Sexual activity after myocardial infarction CMAJ 1977; 116: 1250-1253.
28. Paolillo V, Marra S, Spadaccini F, Angelino PF. Dynamic electrocardiographic recording during sexual activity in recent post-myocardial infarction and revascularization patients [letter]. Am Heart J 1980; 100: 763.
29. Health United States. 1998 Hyattsville, Maryland: US National Center for Health Statistics, 1998
30. Australian Institute of Health and Welfare. Heart, stroke and vascular diseases, Australian facts. Canberra: AIHW and the Heart Foundation of Australia, 1999. (Cardiovascular Disease Series No. 10, AIHW Cat. No. CVD 7.)
31. Australian Bureau of Statistics. Causes of death, Australia Canberra: ABS, 1997. (Cat No. 3303.0.)
32. Cardiac rehabilitation: sex after a heart attack. In: Zaret BL, Moser M, Cohen LS, editors. Yale University School of Medicine Heart Book. New York: Hearst Books, 1992; 351.
33. Tardif GS. Sexual activity after a myocardial infarction. Arch Phys Med Rehabit 1989; 70: 763-766.
34. Summary statement of the American College of Cardiology and the American Heart Association on the use of sildenafil (Viagra) in patients at clinical risk from cardiovascular effects. 10 August 1998. 〈http://www americanheart.org/Whats_News/AHA_Science_Advisories/viagra.html〉. Accessed 18 February 2000.
35. Fact sheet for prevention of myocardial infarction. National Heart Foundation of Australia, Curr Ther 1999; 39: 52.
36. Fact sheet for angina. National Heart Foundation of Australia. Curr Ther 1999; 39: 63.
37. Grundy SM, Balady GJ, Criqui MH, et al. Guide to primary prevention of cardiovascular diseases. A statement for healthcare professionals from the Task Force on Risk Reduction. Circulation 1997; 95: 2329-2331.
38. Heart Foundation of Australia. Guide for the use of lipid lowering drugs in adults. Canberra: Heart Foundation of Australia, 1999, Available at 〈http://www. heartfoundation.com.au/include/defaultStory.asp?OwnerUID=200&Content Type=tblcategory〉.
39. Mitka M. Some men who take Viagra die - why? [news]. JAMA 2000; 283(5). 〈http://jama.ama-assn.org/issues/v283n5/full/jmn0202-2.html〉. Accessed 18 February 2000